AU1175099A - Agent for prophylaxis and treatment of panic disorder - Google Patents

Agent for prophylaxis and treatment of panic disorder

Info

Publication number
AU1175099A
AU1175099A AU11750/99A AU1175099A AU1175099A AU 1175099 A AU1175099 A AU 1175099A AU 11750/99 A AU11750/99 A AU 11750/99A AU 1175099 A AU1175099 A AU 1175099A AU 1175099 A AU1175099 A AU 1175099A
Authority
AU
Australia
Prior art keywords
prophylaxis
agent
treatment
panic disorder
panic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11750/99A
Inventor
Guy Griebel
Ghislaine Perrault
David J. Sanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU1175099A publication Critical patent/AU1175099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11750/99A 1998-11-19 1998-11-19 Agent for prophylaxis and treatment of panic disorder Abandoned AU1175099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1998/005233 WO2000030645A1 (en) 1998-11-19 1998-11-19 Agent for prophylaxis and treatment of panic disorder

Publications (1)

Publication Number Publication Date
AU1175099A true AU1175099A (en) 2000-06-13

Family

ID=14209440

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11750/99A Abandoned AU1175099A (en) 1998-11-19 1998-11-19 Agent for prophylaxis and treatment of panic disorder

Country Status (2)

Country Link
AU (1) AU1175099A (en)
WO (1) WO2000030645A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038708T3 (en) * 1987-03-02 1996-07-16 Yoshitomi Pharmaceutical METHOD FOR PRODUCING BENZOTIEPINE (5,4-C) PIRIDAZINE COMPOUNDS.

Also Published As

Publication number Publication date
WO2000030645A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
AU6872498A (en) Method and composition for skin treatment
ZA9810788B (en) Method and composition for the treatment and prevention of hyperuricemia
AU2389600A (en) Reservoir-and-filter system and method of use
AU2469599A (en) Methods for the prevention and treatment of fibrosis and sclerosis
AU1556497A (en) Agents for the treatment and prevention of aids
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
GB9409336D0 (en) Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis
AU2115799A (en) Composition and method for treatment and prevention of arthritis and/or autoimmune diseases
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
WO2001093878A8 (en) Bismuth compounds for the treatment and prevention of mucositis
AU4636199A (en) Method of reducing or preventing malodour
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU2742799A (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
GB2343844B (en) Composition and method for treatment of hypertrophic skin accumlations and their prevention
AU3607597A (en) Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
AU2964199A (en) Prevention and treatment of adhesions
AU4525299A (en) Method of reducing or preventing malodour
AU1175099A (en) Agent for prophylaxis and treatment of panic disorder
HUP0101299A3 (en) Use of topiramate and derivatives for manufacturing medicament useful for treating schizophrenia
AU4480999A (en) Use of selenium compounds for preventing and treating Alzheimer disease
AU5536899A (en) Synthetically prepared composition for treatment and/or prophylaxis of overweight, and use thereof
AU4556899A (en) Prevention and treatment of sepsis
IL138484A0 (en) Treatment of panic attacks
AU1392601A (en) Prevention and treatment of biomaterial-associated infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase